BF
BOK Financial Portfolio holdings
AUM
$6.17B
1-Year Return
16.76%
This Quarter Return
+8.06%
1 Year Return
+16.76%
3 Year Return
+71.13%
5 Year Return
–
10 Year Return
–
AUM
$4.55B
AUM Growth
+$301M
(+7.1%)
Cap. Flow
+$19.7M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
25.34%
Holding
912
New
63
Increased
295
Reduced
438
Closed
60
Top Buys
| 1 |
iShares Russell 1000 ETF
IWB
|
+$52.1M |
| 2 |
Amazon
AMZN
|
+$16.8M |
| 3 |
Qualcomm
QCOM
|
+$10.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$9.13M |
| 5 |
Microsoft
MSFT
|
+$8.97M |
Top Sells
| 1 |
Apple
AAPL
|
+$20.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$7.47M |
| 3 |
Lam Research
LRCX
|
+$6.13M |
| 4 |
Adobe
ADBE
|
+$5.72M |
| 5 |
JPMorgan Chase
JPM
|
+$5.3M |
Sector Composition
| 1 | Technology | 16.83% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 7.71% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Vanguard Value ETF
VTV
$144B
| $1.98M | 0.04% |
18,904
+3,957
| +26% | +$414K |
|
327
Electronic Arts
EA
$42.6B
| $1.96M | 0.04% |
14,996
+2,125
| +17% | +$277K |
|
328
Quest Diagnostics
DGX
$20.1B
| $1.94M | 0.04% |
16,969
-7,176
| -30% | -$821K |
|
329
Northern Trust
NTRS
$24.2B
| $1.94M | 0.04% |
24,830
-960
| -4% | -$74.9K |
|
330
ResMed
RMD
$39.6B
| $1.94M | 0.04% |
11,288
-1,878
| -14% | -$322K |
|
331
Brighthouse Financial
BHF
$2.79B
| $1.93M | 0.04% |
71,748
-6,561
| -8% | -$177K |
|
332
Neurocrine Biosciences
NBIX
$14B
| $1.92M | 0.04% |
19,927
+978
| +5% | +$94K |
|
333
SPDR Gold Trust
GLD
$115B
| $1.9M | 0.04% |
10,722
-385
| -3% | -$68.2K |
|
334
Vanguard Mid-Cap Growth ETF
VOT
$17.7B
| $1.88M | 0.04% |
10,424
+276
| +3% | +$49.7K |
|
335
ASML
ASML
$312B
| $1.88M | 0.04% |
5,081
-58
| -1% | -$21.4K |
|
336
Infosys
INFY
$70.4B
| $1.88M | 0.04% |
135,771
| – | – |
|
337
Reliance Steel & Aluminium
RS
$15.4B
| $1.87M | 0.04% |
18,287
+555
| +3% | +$56.6K |
|
338
Hilton Worldwide
HLT
$64.2B
| $1.86M | 0.04% |
21,777
-827
| -4% | -$70.6K |
|
339
DexCom
DXCM
$29.8B
| $1.85M | 0.04% |
17,940
+1,868
| +12% | +$193K |
|
340
Global Payments
GPN
$20.6B
| $1.85M | 0.04% |
10,414
-9,342
| -47% | -$1.66M |
|
341
Brown-Forman Class B
BF.B
$12.9B
| $1.84M | 0.04% |
24,486
-5,112
| -17% | -$385K |
|
342
Paycom
PAYC
$12.4B
| $1.84M | 0.04% |
5,903
+65
| +1% | +$20.2K |
|
343
Travelers Companies
TRV
$61.3B
| $1.82M | 0.04% |
16,803
-23,415
| -58% | -$2.53M |
|
344
Sherwin-Williams
SHW
$89.1B
| $1.81M | 0.04% |
7,803
-441
| -5% | -$102K |
|
|
INFO
345
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.81M | 0.04% |
23,021
+72
| +0.3% | +$5.66K |
|
346
Enbridge
ENB
$106B
| $1.8M | 0.04% |
61,786
+2,169
| +4% | +$63.3K |
|
347
Manhattan Associates
MANH
$12.8B
| $1.78M | 0.04% |
18,662
-3,245
| -15% | -$310K |
|
348
Public Service Enterprise Group
PEG
$40.8B
| $1.76M | 0.04% |
31,961
+1,256
| +4% | +$69K |
|
|
ALXN
349
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.74M | 0.04% |
15,187
+7,630
| +101% | +$873K |
|
350
SBA Communications
SBAC
$20.8B
| $1.74M | 0.04% |
5,455
-28
| -0.5% | -$8.92K |
|